State of Alaska Department of Revenue’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Sell
62,806
-2,054
-3% -$703K 0.23% 67
2026
Q1
$22.8M Buy
64,860
+485
+0.8% +$173K 0.25% 63
2025
Q4
$21.1M Sell
64,375
-1,600
-2% -$508K 0.22% 65
2025
Q3
$18.6M Sell
65,975
-3,034
-4% -$880K 0.19% 79
2025
Q2
$19.3M Sell
69,009
-2,640
-4% -$748K 0.21% 77
2025
Q1
$22.3M Sell
71,649
-3,630
-5% -$1.07M 0.25% 59
2024
Q4
$19.6M Sell
75,279
-1,125
-1% -$334K 0.22% 69
2024
Q3
$24.6M Buy
76,404
+6,790
+10% +$2.22M 0.26% 55
2024
Q2
$21.8M Sell
69,614
-10,072
-13% -$2.96M 0.24% 68
2024
Q1
$22.7M Buy
79,686
+6,900
+9% +$2.02M 0.26% 64
2023
Q4
$21M Sell
72,786
-3,740
-5% -$1.02M 0.25% 67
2023
Q3
$20.6M Sell
76,526
-2,595
-3% -$648K 0.26% 61
2023
Q2
$17.6M Sell
79,121
-11,895
-13% -$2.76M 0.21% 79
2023
Q1
$22M Sell
91,016
-980
-1% -$241K 0.26% 68
2022
Q4
$24.2M Buy
91,996
+763
+0.8% +$205K 0.3% 60
2022
Q3
$20.6M Sell
91,233
-3,331
-4% -$807K 0.28% 64
2022
Q2
$23M Sell
94,564
-16,485
-15% -$4.04M 0.28% 64
2022
Q1
$26.9M Sell
111,049
-4,985
-4% -$1.15M 0.28% 57
2021
Q4
$26.1M Sell
116,034
-10,071
-8% -$2.13M 0.25% 75
2021
Q3
$26.8M Sell
126,105
-6,943
-5% -$1.6M 0.27% 65
2021
Q2
$32.4M Sell
133,048
-311
-0.2% -$76.5K 0.33% 55
2021
Q1
$33.2M Sell
133,359
-4,661
-3% -$1.11M 0.36% 47
2020
Q4
$31.7M Sell
138,020
-14,787
-10% -$3.41M 0.36% 49
2020
Q3
$38.8M Buy
152,807
+19,716
+15% +$4.88M 0.48% 31
2020
Q2
$31.4M Buy
133,091
+25,557
+24% +$5.83M 0.4% 43
2020
Q1
$21.8M Buy
107,534
+4,741
+5% +$1.04M 0.34% 53
2019
Q4
$24.8M Sell
102,793
-9,043
-8% -$1.99M 0.32% 54
2019
Q3
$21.6M Buy
111,836
+19,592
+21% +$3.76M 0.29% 59
2019
Q2
$17M Buy
92,244
+772
+0.8% +$138K 0.29% 83
2019
Q1
$17.4M Sell
91,472
-3,886
-4% -$742K 0.31% 66
2018
Q4
$18.6M Sell
95,358
-868
-0.9% -$169K 0.36% 59
2018
Q3
$19.9M Sell
96,226
-1,196
-1% -$236K 0.34% 63
2018
Q2
$18M Buy
97,422
+17,350
+22% +$3.07M 0.32% 64
2018
Q1
$13.6M Buy
80,072
+7,790
+11% +$1.43M 0.28% 78
2017
Q4
$12.6M Buy
72,282
+65,752
+1,007% +$11.6M 0.3% 70
2017
Q3
$1.22M Buy
6,530
+680
+12% +$120K 0.06% 367
2017
Q2
$1.01M Buy
5,850
+410
+8% +$66.7K 0.07% 249
2017
Q1
$892K Sell
5,440
-1,050
-16% -$174K 0.07% 259
2016
Q4
$948K Buy
6,490
+4,140
+176% +$623K 0.09% 214
2016
Q3
$392K Sell
2,350
-3,640
-61% -$616K 0.04% 284
2016
Q2
$911K Sell
5,990
-200
-3% -$31.1K 0.09% 210
2016
Q1
$928K Buy
+6,190
New +$920K 0.1% 204

Other funds holding AMGN

State of Alaska Department of Revenue's AMGN Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Amgen (AMGN) stake by 3.2% in Q2 2026, selling an estimated $703K and leaving 62,806 shares worth $22.7M. The position accounts for 0.23% of the portfolio, ranked #67.

State of Alaska Department of Revenue first reported a position in AMGN in Q1 2016 and has held it in 42 quarters since. The position peaked at $38.8M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • State of Alaska Department of Revenue held 62,806 shares of Amgen worth $22.7M as of Q2 2026.
  • State of Alaska Department of Revenue sold 2,054 Amgen shares in Q2 2026, an estimated $703K.
  • Amgen made up 0.23% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #67 holding.
  • State of Alaska Department of Revenue first reported a position in Amgen in Q1 2016 and has held it in 42 quarters since.
  • State of Alaska Department of Revenue's Amgen position peaked at $38.8M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.